Blood pressure, cardiovascular outcomes and sodium intake, a critical review of the evidence

Acta Clinica Belgica

Volumn 67, Issue 6, 2012, Pages 403-410

  Stolarz Skrzypek, K ^a   Liu, Y ^b   Thijs, L ^b   Kuznetsova, T ^b   Czarnecka, D ^a   Kawecka Jaszcz, K ^a   Staessen, J A ^b,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Blood pressure; Cardiovascular mortality; Cardiovascular outcomes; Salt; Sodium

Indexed keywords

SODIUM CHLORIDE;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; ESSENTIAL HYPERTENSION; FOOD FREQUENCY QUESTIONNAIRE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS (TOPIC); MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SODIUM EXCRETION; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; HYPERTENSION; MORTALITY; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALT INTAKE; URINE;

ANIMALS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; GUIDELINES AS TOPIC; HUMANS; HYPERTENSION; NUTRITION SURVEYS; RISK ASSESSMENT; RISK FACTORS; SODIUM CHLORIDE, DIETARY;

MLCS; MLOWN;

EID: 84874807380     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.2143/ACB.67.6.2062704     Document Type: Conference Paper

References (57)

1. Robertson JIS. Dietary salt and hypertension: A scientific issue or a matter of faith? J Eval Clin Pract 2003; 9: 1-22. (Pubitemid 36193620)
2. Alderman MH. Reducing dietary sodium. The case for caution. JAMA 2010; 303: 448-449.
3. Anonymous. Salt and cardiovascular disease mortality. Lancet 2011; 377: 1626.
4. Prospective Studies Collaboration. Age-specific relevance of usual blood pres-sure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
5. Palar K, Sturm R. Potential societal savings from reduced sodium consumption in the U.S. adult population. Am J Health Promot 2009; 24: 49-57.
6. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease. A cost-effectiveness analysis. Ann Intern Med 2010; 152: 481-487.
7. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590-599.
8. Staessen J, Bulpitt C, Fagard R, Joossens JV, Lijnen P, Amery A. Four urinary cations and blood pressure. A population study in two Belgian towns. Am J Epidemiol 1983; 117: 676-687. (Pubitemid 13100719)
9. Smith WCS, Crombie IK, Tavendale RT, Gulland SK, Tunstall-Pedoe HD. Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish Heart Health study. BMJ 1988; 297: 329-330.
10. Graudal NA, Hubeck-Graudal T, Jürgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012; 25: 1-15.
11. Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P, Amery A. Salt intake and blood pressure in the general population: A controlled intervention trial in two towns. J Hypertens 1988; 6: 965-973. (Pubitemid 19041643)
12. Staessen JA, Lijnen P, Thijs L, Fagard R. Salt and blood pressure in community-based intervention trials. Am J Clin Nutr 1997; 65 (suppl): 661S-670S. (Pubitemid 27063067)
13. Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol 2008; 93: 177-209.
14. Guyton AC. Long-term arterial pressure control: An analysis from animal experiments and computer and graphic models. Am J Physiol 1990; 259: R865-R877. (Pubitemid 20387146)
15. Visser FW, Boonstra AH, Titia Lely A, Boomsma F, Navis G. Renal response to angiotensin II is blunted in sodium-sensitive men. Am J Hypertens 2008; 21: 323- 328. (Pubitemid 351323277)
16. Luft FC. Molecular aspects of genetics of salt-sensitivity and hypertension. Drug Metab Dispos 2003; 29: 500-504.
17. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 1629-1641. (Pubitemid 36579003)
18. Beretta-Piccoli C, Weidmann P, Brown JJ, Davies DL, Lever AF, Robertson JIS. Body sodium and blood volume state in essential hypertension: Abnormal rela-tion of exchangeable sodium to age and blood pressure in male patients. J Car-diovasc Pharmacol 1984; 6 (suppl. 1): S134-S142. (Pubitemid 14123981)
19. Titze J, Machnik A. Sodium sensing in the interstitium and the relationship to hypertension. Curr Opin Nephrol Hypertens 2010; 19: 385-362.
20. Campese VM. Salt-sensitive hypertension: renal and cardiovascular implica-tions. Nutr Metab Cardiovasc Dis 1999; 9: 143-156. (Pubitemid 129632900)
21. Adrogué HJ, Madias NE. Sodium and potassium in the pathogenesis of hyper-tension. N Engl J Med 2007; 356: 1966-1978.
22. Intersalt Cooperative Research Group. Intersalt: An international study of elec-trolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319-328.
23. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovský J, Kawecka-Jaszcz K, Niki-tin Y, Staessen JA, on behalf of the European Project on Genes in Hyperten-sion EPOGH) Investigators. Fatal and nonfatal outcomes, incidence of hyperten-sion and blood pressure changes in relation to urinary sodium excretion in White Europeans. JAMA 2011; 305: 1777-1785.
24. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr., Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA, for the TONE Collabora-tive Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons. A randomized controlled trial of nonpharmaco-logic interventions in the elderly (TONE). JAMA 1998; 279: 839-846. (Pubitemid 28185548)
25. Grobbee DE, Hofman A. Does sodium restriction lower blood pressure? BMJ 1986; 293: 27-29. (Pubitemid 16093235)
26. Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure. A meta- Analysis of randomized controlled trials. JAMA 1996; 275: 1590-1597. (Pubitemid 26154246)
27. Cutler JA, Follmann DF, Allender PS. Randomized trials of sodium reduction: An overview. Am J Clin Nutr 1997; 65 (suppl): 643S-651S. (Pubitemid 27063065)
28. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004; Issue 3. Art. No.: CD004937.
29. He J, Whelton PK, Appel LJ, Charleston J, Klag MJ. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000; 35: 544-549. (Pubitemid 30108146)
30. Chien KL, Hsu HC, Chen PC, Su TC, Chang WT, Chen MF, Lee YT. Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan. J Hypertens 2008; 26: 1750- 1756.
31. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995; 1: 1009-1016.
32. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hyper-tensive men. Hypertension 1995; 25: 1144-1152.
33. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Com-parison of the prediction by 27 different factors of coronary heart disease and death in men and woman of the Scottish Heart Health Study: cohort study. BMJ 1997; 315: 722-729. (Pubitemid 27405828)
34. Tuomilehto J, Jousilahti P, Rastenyte D, Moitchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: A prospective study. Lancet 2001; 357: 848-851. (Pubitemid 32239370)
35. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK, for the Trials of Hypertension Prevention Collaborative Research Group. Long term effects of dietary sodium reduction on cardiovas-cular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885-888. (Pubitemid 46724330)
36. Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK, for the Trials of Hypertension Prevention Collaborative Research Group. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: The Trials of Hypertension Prevention (TOHP) follow-up study. Arch Intern Med 2009; 169: 32-40.
37. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19: 1349-1358. (Pubitemid 32730451)
38. Kuznetsova T, Staessen JA, Kawecka-Jaszcz K, Babeanu S, Casiglia E, Filipovský J, Nachev C, Nikitin Y, Peleška J, O'Brien E, on behalf of the EPOGH Investigators. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit 2002; 7: 215-224.
39. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolo-nen N, Saraheimo M, Gordin D, Groop PH, for the FinnDiane Study Group. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabet Care 2011; 34: 861-866.
40. Ekinci EL, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G. Dietary salt intake and mortality in patients with type 2 diabetes. Diabet Care 2011; 34: 703-709.
41. Kagan A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985; 16: 390-396. (Pubitemid 15034418)
42. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 2027-2034.
43. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: The National Health and Nutrition Examination Survey (NHANES I). Lancet 1998; 351: 781-785. (Pubitemid 28112339)
44. Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). J Gen Intern Med 2008; 23: 1297-1302.
45. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med 2006; 119: 275.e7-275e14.
46. Geleijnse JM, Witteman JCM, Stijnen T, Kloos MW, Hofman A, Grobbee DE. Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: The Rotterdam study. Eur J Epidemiol 2007; 22: 763-770. (Pubitemid 350105371)
47. Umesawa M, Iso H, Date C, Yamamoto A, toyoshima H, Watanabe Y, Kikuchi S, Koizumi A, Kondo T, Inaba Y, Tanabe N, Tamakoshi A, the JACC Study Group. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: The Japan Collaborative Cohort Study for Evaluation of Cancer Risks. Am J Clin Nutr 2008; 88: 195-202. (Pubitemid 351988704)
48. Yang Q, Liu T, Kuklina E, Flanders D, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB. Sodium and potassium intake and mortality among US adults. Arch Intern Med 2011; 171: 1183-1191.
49. O'Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, McQueen M, Sleight P, Sharma AM, Dans A, Probstfield J, Schmieder RE. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306: 2229-2238.
50. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C, ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559. (Pubitemid 351522739)
51. Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, TRANSCEND Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised con-trolled trial. Lancet 2008; 372: 1174-1183.
52. Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: A meta-analysis of randomized con-trolled trials (Cochrane Review). Am J Hypertens 2011; 115: 1-10.
53. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardio-vascular disease: meta-analysis of prospective studies. BMJ 2009; 339: b4567.
54. Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G. Short- And long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 2002; 106: 1957-1961. (Pubitemid 35176301)
55. Garg K, Williams GH, Hurwitz S, Brown NJ, Hopkins PN, Adler GK. Low-salt diet increases insulin resistance in healthy subjects. Metabolism 2011; 60: 965-968.
56. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104.
57. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SCJ, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke. A call to action from the American Heart Association. Circulation 2011; 123: 1138-1143.